English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSince the COVID-19 pandemic, rates of chronic absenteeism have nearly doubled across the nation for students in kindergarten through grade 12.This increase was tied to the mode of instruction during the early years of the pandemic.
Tag: COVID -19
St. Jude identifies SARS-CoV-2 “mimic” contributing to pediatric inflammatory syndrome
Discover St. Jude research from Paul Thomas, PhD, linking SARS-CoV-2 infections and molecular mimicry with multisystem inflammatory syndrome in children.
Research reveals more people died from hot or cold weather conditions than COVID-19 in parts of UK
Research has highlighted how weather extremes worsened by climate change are now a major national public health threat.
Negotiations for a Global Pandemic Agreement Extended
Member States of the World Health Organization (WHO) were due to converge on text for a global pandemic agreement during their ninth and final negotiating session in March; however, insufficient progress was made in those two weeks, in terms of finding consensus.
NEW STUDY REVEALS COVID-19 MAY HAVE ORIGINATED IN A LAB
Research from the journal Risk Analysis, examined the likelihood of COVID-19 coming from an unnatural origin (i.e. from a laboratory.)
COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection
A large, binational study found that SARS-CoV-2 infection was associated with an increased risk for autoimmune inflammatory rheumatic diseases (AIRDs) that extends up to 12 months after infection. The risk was found to be higher with greater severity of acute COVID-19, even among those who were vaccinated. These findings suggest that care strategies for patients who survive COVID-19 should pay close attention to manifestations of AIRD, particularly after severe illness. The study is published in Annals of Internal Medicine.
MSU co-authored study: 10 insights to reduce vaccine hesitancy on social media
Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.
Study Could Help Clear Up Confusion and Hesitancy Surrounding RSV Vaccines
Efforts to vaccinate vulnerable populations against respiratory syncytial virus (RSV) faced an uphill battle this season. However, now a new study by researchers at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) could help to combat RSV vaccine misinformation and quell vaccine…
Researchers Use a Novel Approach to Design a COVID-19 Antiviral Drug
Researchers combined the features of clinical drugs to treat hepatitis C and viruses similar to COVID-19. This allowed them to synthesize BBH-1, a promising inhibitor that targets the breakdown of the SARS-CoV-2 virus. The researchers characterized samples using X-ray and neutron diffraction techniques to provide atomic-level insights on the structure of the BBH-1 inhibitor and how it binds to the SARS-CoV-2 protein.
New Insights on Long COVID
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. What is long COVID, and how common is it? (SOT@ :14, TRT :32) Why do some people get…
Study links childhood trauma to COVID-19 deaths, hospitalizations
People who endured childhood adversity, like abuse or neglect, were 12-25% more likely to be hospitalized or die from COVID-19 in adulthood, a new University of Pittsburgh study found.
Domestic violence involving firearms increased in Chicago, Los Angeles and Nashville during pandemic
Domestic violence went down or stayed the same during the first 10 months of the COVID-19 pandemic in five major U.S. cities. However, domestic violence involving firearms increased in three of those cities, according to a new UC Davis study published in the Journal of Family Violence.
Researchers Show SARS-Cov-2 Infection Affects Energy Stores in the Body, Causing Organ Failure
An international research team, including Jonathan C. Schisler, PhD, in the UNC School of Medicine, has found how SARS-CoV-2 causes widespread “energy outages” throughout major organs, and how these effects contribute to debilitating long COVID symptoms.
Nirmatrelvir-ritonavir not effective for reducing most post-COVID-19 conditions
A trial emulation study of veterans with COVID-19 found that the use of the antiviral nirmatrelvir–ritonavir was not effective for reducing the risk for many post-COVID-19 conditions, including cardiac, pulmonary, renal, gastrointestinal, neurologic, mental health, musculoskeletal, or endocrine symptoms. Nirmatrelvir–ritonavir was associated only with a reduced risk for combined thromboembolic events. The study is published in Annals of Internal Medicine.
New research looks at life satisfaction in pandemic-era teens with mental health histories
New research from the NIH’s Environmental influences on Child Health Outcomes (ECHO) Program suggests that during the COVID-19 pandemic, some teens with a history of depression, anxiety, autism and ADHD experienced more severe impacts than those without. This research, titled…
Post-COVID condition is not linked to ongoing infection or active brain damage
Post COVID-19 condition does not appear to be linked to direct viral invasion of the brain or active brain damage. This has been shown by a study at the University of Gothenburg. Searching for abnormal biomarkers among the participants yielded no hits in either blood or cerebrospinal fluid samples
People with severe mental illness at 50 per cent higher risk of death following COVID-19 infection
New research from King’s College London has found that in the UK people with severe mental illness were at increased risk of death from all causes following COVID-19 infection compared to those without severe mental illness
Convalescent plasma reduces mortality by 10% in COVID-19 patients in acute respiratory distress and on artificial respiratory assistance
Convalescent plasma reduces COVID-19 mortality by 10% in patients on artificial ventilation
Global platform study presents results to guide care of severely ill patients with COVID-19 using routinely available drugs
The world’s largest trial of multiple interventions for critically ill adults with COVID-19 has simultaneously released results about two of its treatments, vitamin C and simvastatin
Broad-spectrum antiviral candidate targets dengue and SARS-CoV-2
A broad-spectrum antiviral drug candidate, 2-thiouridine, that targets positive-strand RNA viruses has been identified and characterized.
Medicine on the base of vitamin B6 improves memory and decreases fatigue after COVID
Scientists have showed that medicine on the base of vitamin B6 can be used for treatment of post-COVID asthenia – condition when patients complain of rapid fatigability, problems with memory and sleep. Taking of this product enabled 35% patients to improve memory, 40% patients began to sleep well, 42% of people began to get tired more slowly. Besides this taking this medicine enabled patients to experience physical activity easier. Results of the research are published in Magazine of Infectology.
Canadians with peptic ulcer disease faced mental health challenges during COVID-19 pandemic
The risk of depression among those with peptic ulcer disease was higher among women, those who felt lonely, those with functional limitations, those whose income did not satisfy their basic needs and those who experienced pandemic-related stressors
Public health interventions prevented transmission within BU most SARS-CoV-2 cases
Findings have implications for transmission protocols for other respiratory diseases
Holy immunity! Bat genes key against COVID, cancer
Bats have acquired remarkable traits throughout their evolution. They’re the only mammals that can fly, and they live much longer than other animals their size. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola. It also keeps bats relatively cancer-free. How? According to Cold Spring Harbor Laboratory (CSHL) scientists, it’s all in the genes.
Targeting a coronavirus ion channel could yield new Covid-19 drugs
Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation
GW Experts Available: CDC Report Finds Older Adults Make Up Two-Thirds of Covid-19 Hospitalizations
WASHINGTON (October 11, 2023) – According to a recent report by the U.S. Centers for Disease Control and Prevention, adults 65 and older accounted for nearly two-thirds of Covid-19 hospitalizations in the United States this year, 61% of intensive care unit admissions and…
Could a specialized diet alleviate long COVID?
Approximately 7% of Americans have had long COVID, a range of ongoing health problems experienced after infection and recovery from COVID-19. Symptoms can include fatigue, brain fog, headaches, chest pain, heart palpitations and more.
Free At-Home COVID Tests and Paxlovid
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. Are COVID cases starting to go down? (SOT@ :14, TRT :49) How reliable are at-home COVID tests? Can…
Scientists discover ‘long colds’ may exist, as well as long Covid
A new study from Queen Mary University of London, published in The Lancet’s EClinicalMedicine, has found that people may experience long-term symptoms —or ‘long colds’—after acute respiratory infections that test negative for COVID-19.
New study reveals Australian Long COVID response lagging
New research by RMIT University and Northern Health has examined Australia’s Long COVID services, guidelines and public health information, compared with international standards.
Johns Hopkins Bloomberg School of Public Health Media Briefing on Preventing the Spread of Flu, COVID, and RSV This Fall
The Johns Hopkins Bloomberg School of Public Health is hosting an expert briefing for the media from 2:00 p.m. to 2:30 p.m. EDT, Thursday, October 12, on how to take steps to stay healthy as COVID and RSV cases climb and flu season approaches.
Virginia Tech’s Linsey Marr named 2023 MacArthur Fellow
Linsey Marr, the Charles P. Lunsford Professor and a University Distinguished Professor at Virginia Tech, has been named a 2023 MacArthur Fellow, a highly prestigious award commonly called a “genius grant.” The John D. and Catherine T. MacArthur Foundation announced Wednesday that Marr is one of 20 fellows who will receive an $800,000 award.
Pandemic boosted gardening, hunting in NYS
A survey of New York state residents found that nearly half of respondents increased the amount of time they spent on wild and backyard food in the early months of the COVID-19 pandemic – confirming anecdotes about increases in activities such as sourdough baking, fishing and gardening.
MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine
The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.
Pharmacists can improve access to life-saving vaccines
HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.
Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West
The COVID-19 pandemic spotlighted how a rapid and effective response to infectious disease outbreaks is critical for saving lives and protecting communities. With a $17.5 million, five-year grant from the U.S. Centers for Disease Control and Prevention (CDC), University of Utah researchers, in collaboration with Washington State University, are leading efforts to provide data and tools that guide decisions to improve responses to emerging public health threats in the Mountain West.
Study finds SARS-CoV-2-associated sepsis was more common, deadly than previously thought
Using data from Mass General Brigham’s electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic
Katalin Karikó and Drew Weissman, Penn’s Historic mRNA Vaccine Research Team, Win 2023 Nobel Prize in Medicine
PHILADELPHIA – The University of Pennsylvania messenger RNA pioneers whose years of scientific partnership unlocked understanding of how to modify mRNA to make it an effective therapeutic—enabling a platform used to rapidly develop lifesaving vaccines amid the global COVID-19 pandemic—have been named winners of the 2023 Nobel Prize in Physiology or Medicine.
Common symptoms of COVID-19 and often-overlooked symptoms
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. COVID-19 has been around for three years now. What are some of the recent common symptoms we are seeing? (SOT@…
Rutgers Experts on School Climate and Conditions for Learning Available to Comment on Post-COVID Educational Challenges
Dr. Alicia Raia-Hawrylak, Co-Project Manager for the School Climate Transformation Project (SCTP), is available to comment on post-COVID concerns related to school climate, including student behavior and bullying, social and emotional learning, staff retention, and using data to guide the…
Distinct immune, hormone responses shed light on mysteries of long COVID
People who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with the COVID-19 virus exhibit different immune and hormonal responses to the virus than those not diagnosed with long COVID.
Six Numbers Predict Life-Threatening COVID-19
Rutgers develops a prognosis tool to help hospitals improve care.
Avoiding a “Tripledemic” This Winter
A Rutgers infectious disease expert explains what you need to know about this year’s flu, COVID and new RSV shots
Study details immune cells vital to success of vaccines against coronavirus
A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.
When it comes to COVID and the flu, an expert is available to speak about infection prevention and safety control
https://case.edu/nursing/about/fpb-directories/faculty-directory/shanina-c-knighton
Global Policymakers Call for Effective Infodemic Management to be a Substantive Article in the Pandemic Accord
Members of the Intergovernmental Negotiating Body Bureau continue the discussion on infodemic management in light of circulation of misinformation through social media during public health emergencies.
Five New Health Systems Partner with American Thoracic Society on Vaccine Initiative
As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.
The Latest in Science and Medical Advancement in Otolaryngology-Head and Neck Surgery to be Presented at AAO-HNSF Annual Meeting
The latest research and advances in otolaryngology-head and neck surgery will be presented in Nashville, Tennessee, during the AAO-HNSF 2023 Annual Meeting & OTO Experience, September 30 – October 4.
Global background rates study analyzes data from 197 million people for assessment of COVID-19 vaccine safety
The US CDC (Centers for Disease Control and Prevention) funded Global COVID Vaccine Safety Project has generated background incidence rates on a range of conditions designated as AESI (Adverse Events of Special Interest) for COVID-19 vaccine safety monitoring. Conditions studied included myocarditis, pulmonary embolism, and Guillain-Barré syndrome.
Cell therapy can reduce risk of death from COVID-19 by 60%, study shows
The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.